No Password Required: MITRE Engage Lead, Innovator in Cyber Deception, and Dance Community Builder
Podcast: Interoperability: Health Care's Next Disruptor Is openEHR - Diagnosing Health Care
Podcast: Interoperability: A New Vision Through openEHR - Diagnosing Health Care
Podcast–Interoperability: How Far We’ve Come and Where We’re Going - Diagnosing Health Care
Interview With Ayesha Minhaj, Google - Digital Planning Podcast
Inside Privacy Law: The Regulation of Personal Data
Oklahoma: Changing Data Privacy as We Know It?
M365 in 5 – Part 7: Teams Audio/Video (A/V) Conferencing
M365 in 5 – Part 3: OneDrive for Business – Protected personal collaboration
M365 in 5 – Part 2: SharePoint Online – The new file-share environment
Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?
Compliance Perspectives: The Ethics of Data
Tackling Modern Attachment and Link Challenges in G-Suite, Slack, and Teams
From NC State to Changing the State of Health Information Networks, with Medicom Technologies’ Malcolm Benitz
U.S. Department of Defense Awards Contract to Secure Sensitive Data With Blockchain
Global privacy in the age of COVID-19
Compliance Perspectives: Permissible Disclosures under HIPAA, Especially in the Time of COVID-19
Compliance Perspectives: COVID-19 and GDPR
Jones Day Presents: Antitrust, Collusion, and Blockchains
[WEBINAR] Laying the Foundation for Maximizing Benefits Around Emerging Technologies
The EU regulation designed to facilitate secondary use of clinical data for research brings benefits for health research, but also poses challenges for companies....more
The final guidance describes FDA’s enforcement discretion policy for sharing scientific information on unapproved uses of approved products and suggests a safe harbor for sharing off-label information consistent with the...more
The German Federal Court of Justice (Bundesgerichtshof), tasked with resolving a conflict between two competing pharmacists, sought guidance from the Court of Justice of the European Union ("CJEU") on interpreting the General...more
As part of the Real-World Evidence Program, the U.S. Food and Drug Administration (FDA) has released the final guidance, “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory...more
Both the EU and Germany are taking significant steps to accelerate digitalization in the health sector and facilitate the exchange and use of health data for research and innovation purposes. They aim to improve...more
Navigating the complex landscape of drug discovery requires innovative strategies and interdisciplinary collaborations spanning biotechnology, pharmacology, medicine and engineering. As the cost of developing new drugs...more
The Federal Trade Commission (FTC) didn’t mince words. On September 2021, it called out the health app industry for failing to understand the agency’s Health Breach Notification Rule (HBNR) and for not disclosing its...more
Yes. While only one of the pharmaceutical companies within the Fortune 500 states that they sell personal information, the company that has disclosed the sale of information is posting a “Do Not Sell My Personal...more
Most have, but some have not. While the majority of pharmaceutical companies within the Fortune 500 affirmatively state that they do not sell personal information, a significant minority have been silent, or unclear, about...more
Blockchain Initiatives in Healthcare and Other Industries Target Data Integrity, Speed and Analytics - Last week, a not-for-profit alliance of life sciences industries firms announced an expansion of its blockchain project...more
Clinical trials starting patient enrollment this year must include a "data sharing plan" in their trial registrations (such as on ClinicalTrials.gov), according to a policy published by the International Committee of Medical...more
Blockchain—the tamper-proof electronic ledger network technology—first made headlines with the rise of cryptocurrencies like Bitcoin. Independent of that boom-and-bust cycle, the life sciences industry is now exploring ways...more
In a bipartisan effort to combat the opioid crisis, H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (the Act), was enacted on October 24,...more
Making individual patient-level data available for other research presents companies with challenges, but researchers and companies can take steps to minimize the risks. Originally published in Drug and Medical Device,...more
The Cancer Moonshot Task Force has just released its 5 year plan for implementing President Obama’s “Cancer Moonshot” program (“Report”). The initiative, announced during President Obama’s 2016 State of the Union Address, is...more
In a highly anticipated and scrutinized decision, the Centers for Medicare & Medicaid Services (CMS) released a new public data set on April 30, 2015, that includes detailed data regarding the prescribing patterns of...more
Last week, diagnostics services provider Quest Diagnostics and Inserm, the French National Institute of Health and Medical Research institution, announced the launch of BRCA Share, a new datashare initiative that will provide...more
On January 12, 23andMe announced an agreement with Pfizer to provide the drug company with access to anonymous, aggregated information from consumers who bought 23andMe’s test over the past seven years to learn about their...more